Why are Americans turning to personalized medicine?
21 Mar 2023
Why are Americans turning to personalized medicine?

Thanks to massive reductions in the cost of genome sequencing, personalized medicine is meeting demands for autonomy and preventative measures in healthcare. How can brands navigate issues such as data privacy and accessibility and provide people with precise medical treatment?

Michael Morrison

Michael Morrison is a senior researcher in social science with the Centre for Health, Law, and Emerging Technologies (HeLEX) and an associate fellow at the Institute for Science, Innovation, and Society at the University of Oxford. His work deals with the dynamics of innovation in biological and medical technologies, where has worked on a range of topics including human enhancement, biobanking, and regenerative medicine.

Luís Valente

Luís Valente is the co-founder and CEO of iLoF, a digital health company that’s accelerating the future of personalized drug discovery and development through a cloud-based library of disease biomarkers and biological profiles.

Henry Williams

Henry Williams is a writer who covers culture and all things small business. The rest of the time he can be found attempting to write screenplays while he waits for some surfable waves.